Drug doubles immune response against cancer in clinical trial: Study
November 02, 2020 15:18 ISTAccording to the study, published in the journal Proceedings of the National Academy of Sciences, the team hopes the potential treatment might make such tumours more responsive to the class of drugs known as immune checkpoint inhibitors.